Agrivoltaics Looks Good on Paper. The Balance Sheets Say Otherwise.

The market loves a story that resolves two problems at once. Solar panels that also let you grow food on the same acreage? That's the kind of headline that makes ESG funds write checks and policy-makers nod. Even the Vatican — yes, the Vatican — is betting €100 million on it, converting a 430-hectare tract north of Rome into an agrivoltaic plant designed to make the Holy See the world's first carbon-neutral state.

That being the case, you'd think there'd be an obvious stock to buy. There isn't. And the reason reveals a false narrative that runs through the entire clean-energy complex: the assumption that agrivoltaics is simply solar plus agriculture, and that the dual-use premium will magically disappear as scale kicks in.

The data says otherwise. Agrivoltaic projects cost 20% to 40% more per watt than conventional ground-mounted solar. A 2020 benchmarking analysis found the incremental cost at up to $0.80 per watt of capacity on top of standard installation. You need taller racking, more steel, specialized mounting systems, and often single-axis tracking — all of which pile onto the capex bill. And unlike conventional solar, where the economics improve predictably with scale, agrivoltaics projects between 5 and 10 megawatts produce significantly less electricity but operate at a higher cost per megawatt than large conventional installations exceeding 100 MW.

Then there's the agricultural side of the equation. The crops that actually work under solar panels — vegetables, berries, pollinator habitats, and sheep grazing — are labor-intensive and yield-inconsistent. Research from multiple studies shows oat and potato yields falling by approximately 50% as panel row spacing tightens. Lettuce yields swing between significant decreases and slight increases depending on the design. Only 35 agrivoltaic sites in the United States — less than 6% of the total — include actual food crop production, and just 8 of those exceed 1 megawatt.

The investment return reflects the structural friction. Financial modeling estimates agrivoltaic projects deliver an internal rate of return averaging around 8.5% for investors. That's not a typo. Conventional utility-scale solar projects routinely target 10% to 12% IRR on simpler economics. You're paying a premium to earn less.

And scale? As of early 2025, there were fewer than 600 agrivoltaic sites across the United States, covering roughly 65,000 acres. Compared to the estimated 7,290 large utility-scale solar installations, fewer than 200 incorporate any agricultural activity. Eighty-five percent of existing agrivoltaic sites have a capacity under 10 megawatts. This is not an industry on the verge of a breakthrough. It's a niche that's expanding slowly into itself.

So what's an investor supposed to do when the headlines keep telling you agrivoltaics is the future?

The first instinct — and the most common one — is to buy the company selling the infrastructure. Tracker systems, racking, foundations. The name that comes up most often in this space is Array Technologies (NASDAQ: ARRY), which completed its acquisition of APA Solar in August 2025 for $179 million, explicitly positioning itself to serve the dual-use solar market with integrated tracker and foundation solutions.

The problem is, Array Technologies is a financial disaster in progress.

The stock is down 49.1% year-to-date, sitting at $4.69, near its 52-week low of $4.60. Revenue growth was essentially flat at 1.2% year over year. Gross margins have eroded 12.9% year over year to 24.3%. Operating margins are negative at -5.1%. Return on invested capital is -7.3%. The company carries $1.24 billion in total debt against just $296 million in equity — a debt-to-equity ratio of 222%. Free cash flow was positive at $134.7 million, but that came on the back of $28.1 million in capital expenditures, a number so small it barely covers routine maintenance, let alone growth.

The stock trades at 11.7 times forward earnings, which looks cheap until you realize trailing earnings are negative at -4.9 times. The valuation works only if revenue reaccelerates and margins recover simultaneously. Given that revenue growth was 1.2% on the trailing twelve months, that's asking a lot.

Meanwhile, the companies actually making money in solar tell a completely different story.

First Solar (NASDAQ: FSLR) trades at $214, down 18% year-to-date but up 7.1% over the rolling 12-month period. Revenue growth is 23.8% year over year. Gross margins are 41.7%. Operating margins are 31.8%. Free cash flow was $1.5 billion on a trailing twelve-month basis, up 259% year over year. The company carries $1.69 billion in net cash with a debt-to-equity ratio of just 0.36%. Return on equity is 18.5%. Return on invested capital is 17.8%.

First Solar is at 13.2 times trailing earnings, but that multiple is supported by real profitability, not hope. The PEG ratio — price-to-earnings divided by growth rate — sits at 0.34, meaning the stock is cheap relative to its growth trajectory.

The contrast is deliberate. Array Technologies is selling infrastructure into a sector where the end economics don't work. First Solar is selling panels into a sector where conventional utility-scale solar still dominates because the numbers are straightforward. You put panels on the ground, you generate electricity, you sell it at a known price, and you make money. No sheep. No pollinator habitats. No crop yield studies with conflicting results.

The agrivoltaics market is growing — analysts project it could reach $8.7 billion by 2030 at one estimate, or $49.4 billion by 2031 at another. But the fragmentation is the key detail. No single company exceeds 5% of installed capacity. The sector is a collection of specialists, most of them private, selling into policy-driven markets in Europe and Asia where subsidies fill the economics gap. TotalEnergies acquired agrivoltaics leader Ombrea in 2023 to build a 1.5 GW portfolio. Octopus Energy gained a 450 MW pipeline through a 2025 acquisition. But none of these are publicly tradeable bets for the retail investor.

In the United States, the situation is even more constrained. More than 400 of the nation's 3,144 counties have either banned solar development or made it prohibitively difficult. Six states don't allow community-scale solar at all. The 30% investment tax credit for commercial solar under the Inflation Reduction Act is set to expire at the end of 2027. Agrivoltaics was supposed to circumvent local opposition by keeping land in agricultural use. Instead, it just adds another layer of permitting complexity on top of a system that already doesn't work smoothly.

I always keep an eye out for irrational false narratives that frequently take the stock market by storm and lead to some terrific duds — and agrivoltaics is developing into one. The narrative is seductive: two revenue streams on one acre, ESG halo, Pope-approved. The structural reality is that it's a more expensive, harder-to-scale version of solar that delivers lower returns. The infrastructure companies positioned to "benefit" are already telling you that through their balance sheets.

That being the case, my rating on Array Technologies is a Sell. The debt load, negative operating margins, flat revenue growth, and exposure to a sector with fundamentally weak end-economics make it a value trap masquerading as infrastructure growth. The stock's 49% decline year-to-date is not an irrational overreaction — it's the market finally pricing in what the financial statements have been saying for months.

For investors who want solar infrastructure exposure, I favor First Solar as a Buy. The 31.8% operating margin, $1.5 billion in free cash flow, and net cash position of $1.69 billion give it the balance-sheet discipline and profitability quality that the sector's narrative darlings can't match. The company operates in conventional utility-scale solar, where the economics are proven and the scale is real.

The Vatican will get its carbon-neutral solar farm. It has the political will, the extraterritorial privileges, and the appetite for a vanity project that no publicly traded company can replicate. For the rest of us, the investment case is simpler: buy the company that makes money on the physics, not the one that's trying to make money on the poetry.